Consumer group seeks halt to Lilly drug review-WEB ONLY
Consumer health advocates and a patent holder on a highly anticipated blood thinner from Eli Lilly and Co. want the U.S. Food and Drug Administration to halt its review of the drug, which they say may be unsafe at the suggested dose. The FDA has been reviewing Indianapolis-based Lilly’s prasugrel since January 2008. A company […]